Systemic Autoinflammatory Disorder
- Adult-onset Still's disease (AOSD) is a systemic AUTOINFLAMMATORY disorder of the innate immune system - the adult counterpart of systemic juvenile idiopathic arthritis - driven by the IL-1 beta/IL-18 and IL-6 cytokine axis; according to PubMed, IL-18 (and IL-1) reflect inflammasome activation and disease activity, correlating with the Pouchot score, ferritin and CRP.
- The CLASSIC TETRAD is a daily (QUOTIDIAN) SPIKING FEVER, an EVANESCENT SALMON-PINK macular RASH (classically appearing with the evening fever spikes and fading between them), ARTHRALGIA/ARTHRITIS, and a markedly HIGH SERUM FERRITIN (with a characteristically LOW glycosylated ferritin fraction); a very high ferritin in a febrile young adult should raise AOSD.
- Supporting features include sore THROAT, LYMPHADENOPATHY, HEPATOSPLENOMEGALY, serositis, and a neutrophilic LEUCOCYTOSIS, with NEGATIVE ANA and RHEUMATOID FACTOR - the seronegativity is a useful clue distinguishing it from rheumatoid arthritis and lupus.
- DIAGNOSIS uses the YAMAGUCHI criteria (major criteria: fever at least one week, arthralgia at least two weeks, typical rash, leucocytosis with predominant neutrophils; minor: sore throat, lymphadenopathy/splenomegaly, abnormal liver function, negative ANA/RF) and is fundamentally a DIAGNOSIS OF EXCLUSION - infection/sepsis, malignancy (especially LYMPHOMA) and other connective-tissue disease must be excluded first.
- The feared complication is MACROPHAGE ACTIVATION SYNDROME (MAS) - a secondary haemophagocytic lymphohistiocytosis with a hyperferritinaemic cytokine storm (cytopenias, very high ferritin, coagulopathy, organ dysfunction) that is life-threatening and requires urgent recognition and treatment; the disease course may be monocyclic, polycyclic (relapsing) or chronic articular.
- The ORTHOPAEDIC relevance is the CHRONIC ARTICULAR form, which can cause a DESTRUCTIVE ARTHRITIS - classically a non-erosive-to-erosive carpal arthritis progressing to CARPAL/WRIST ANKYLOSIS (a recognised Still's pattern), and sometimes hip/knee involvement needing arthroplasty - while MANAGEMENT is medical: NSAIDs for mild disease, CORTICOSTEROIDS for systemic flares, and methotrexate or, increasingly, IL-1 (anakinra/canakinumab) and IL-6 (tocilizumab) BIOLOGICS for refractory or chronic disease and MAS.
- “AOSD tetrad = QUOTIDIAN spiking fever + EVANESCENT SALMON-PINK rash + arthritis + VERY HIGH FERRITIN (low glycosylated fraction). Seronegative (ANA/RF negative). Autoinflammatory (IL-1/IL-18/IL-6).
- “Yamaguchi criteria; DIAGNOSIS OF EXCLUSION - rule out sepsis, malignancy (lymphoma), other connective-tissue disease. Feared complication = macrophage activation syndrome (MAS).
- “Orthopaedic footprint = chronic destructive arthritis incl. carpal/wrist ankylosis. Treatment: NSAIDs -> steroids -> methotrexate / IL-1 (anakinra) / IL-6 (tocilizumab) biologics.
Young adult with daily spiking fever, an evanescent salmon-pink rash (with the spikes), arthritis, sore throat and a strikingly high ferritin - seronegative (ANA/RF negative). Yamaguchi criteria; a diagnosis of exclusion.
Macrophage activation syndrome - cytopenias, soaring ferritin, coagulopathy, organ failure - is the life-threatening complication. Recognise and treat urgently.
Presentation, Diagnosis & Course
AOSD is a systemic autoinflammatory disorder (IL-1/IL-18/IL-6) presenting with the tetrad of quotidian spiking fever, an evanescent salmon-pink rash, arthralgia/arthritis and a very high ferritin (low glycosylated fraction), plus sore throat, lymphadenopathy, hepatosplenomegaly, serositis and neutrophilic leucocytosis, with negative ANA/RF. Diagnosis uses the Yamaguchi criteria and is a diagnosis of exclusion - sepsis, malignancy (especially lymphoma) and other connective-tissue disease must be ruled out. The course is monocyclic, polycyclic (relapsing) or chronic articular, and the feared complication is macrophage activation syndrome (MAS).
Orthopaedic Relevance & Management
- Orthopaedic footprint: the chronic articular form causes a destructive arthritis - classically a carpal arthritis progressing to carpal/wrist ankylosis (a recognised Still's pattern), and sometimes hip/knee disease needing arthroplasty.
- Medical management (the mainstay): NSAIDs for mild disease; corticosteroids for systemic flares; methotrexate as a steroid-sparing DMARD; IL-1 (anakinra, canakinumab) and IL-6 (tocilizumab) biologics for refractory/chronic disease.
- MAS: urgent recognition and treatment (high-dose steroids, anakinra/ciclosporin) - a medical emergency.
- Perioperative: any joint surgery is undertaken with the rheumatology team, optimising disease control and managing immunosuppression/steroids around surgery.
Adult-onset Still's disease is a diagnosis of exclusion, so the first safety priority is to rule out the serious mimics of a febrile young adult with a high ferritin - sepsis, malignancy (especially lymphoma) and other connective-tissue disease - before settling on AOSD; the seronegativity (negative ANA/RF) and the very high ferritin with a low glycosylated fraction support it, but they do not replace excluding infection and cancer. The second priority is macrophage activation syndrome, a secondary haemophagocytic lymphohistiocytosis that can complicate AOSD: a patient whose ferritin soars further and who develops cytopenias, a falling ESR with rising triglycerides/ferritin, coagulopathy and organ dysfunction may be in a cytokine storm that is rapidly fatal if unrecognised, and needs urgent intensive treatment. For the orthopaedic surgeon, the relevance is mainly the chronic destructive arthritis (notably carpal ankylosis) and the need to coordinate any surgery with the rheumatology team and manage immunosuppression around the procedure.
Evidence & Key Studies
Serum active IL-18 reflects inflammasome activation and disease activity in adult-onset Still's disease
- Inflammasome-mediated activation of IL-1 beta and IL-18 plays a key role in the pathogenesis of adult-onset Still's disease, a systemic autoinflammatory disorder.
- Serum active IL-18 was significantly higher in AOSD than in rheumatoid arthritis, familial Mediterranean fever and healthy controls, and correlated with the Pouchot disease-activity score, ferritin and CRP, decreasing after immunosuppressive therapy.
- Elevated active IL-18 was associated with rash and splenomegaly and had high diagnostic accuracy, supporting its role as a biomarker of inflammasome activation and disease activity.
According to PubMed, the autoinflammatory pathogenesis of AOSD (the central role of the IL-1 beta/IL-18 inflammasome axis, with IL-18 correlating with disease activity, ferritin and CRP) comes from the cited Yoshida study. The classic clinical tetrad (quotidian fever, evanescent salmon-pink rash, arthritis, very high ferritin), the Yamaguchi diagnostic criteria, the status as a diagnosis of exclusion, macrophage activation syndrome as the feared complication, the chronic destructive arthritis (carpal ankylosis), and the treatment ladder (NSAIDs/steroids/methotrexate/IL-1 and IL-6 biologics) are standard, well-established teaching. (See also our Systemic JIA, Rheumatoid Arthritis and Macrophage Activation Syndrome topics.)
Clinical Decision Scenarios
Practise clinical reasoning and management decisions out loud
“A young adult has daily spiking fevers, a salmon-pink rash that comes and goes with the fever, arthritis, and a ferritin of several thousand. What is the diagnosis and how is it managed?”
Mnemonics & Memory Aids
STILL
Hook:STILL: Salmon rash/Sore throat/Seronegative, Temperature (quotidian), IL-cytokines + high ferritin, Lymphadenopathy/Leucocytosis, Look out for MAS (excLusion).
Classic tetrad
- Quotidian (daily) spiking fever
- Evanescent salmon-pink rash (with fever spikes)
- Arthralgia/arthritis + very high ferritin (low glycosylated fraction)
Diagnosis
- Autoinflammatory (IL-1/IL-18/IL-6); seronegative (ANA/RF negative)
- Yamaguchi criteria; sore throat, lymphadenopathy, hepatosplenomegaly, leucocytosis
- Diagnosis of EXCLUSION (sepsis, malignancy/lymphoma, other CTD)
Course & danger
- Monocyclic / polycyclic (relapsing) / chronic articular
- Macrophage activation syndrome (MAS) = life-threatening cytokine storm
- Orthopaedic: chronic destructive arthritis incl. carpal/wrist ankylosis
Management
- NSAIDs (mild) -> corticosteroids (flares) -> methotrexate
- IL-1 (anakinra/canakinumab) and IL-6 (tocilizumab) biologics for refractory/chronic/MAS
- Coordinate joint surgery with rheumatology; manage perioperative immunosuppression